Clinical commentary: Medical ethics and the ramifications of equipoise in clinical research. Is a confirmatory trial using a non-bevacizumab containing arm feasible in patients with recurrent cervical cancer?

Gynecol Oncol. 2014 Sep;134(3):447-9. doi: 10.1016/j.ygyno.2014.06.017. Epub 2014 Jun 27.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Bevacizumab
  • Bioethical Issues*
  • Biomedical Research / ethics*
  • Clinical Trials as Topic / ethics*
  • Ethics, Medical
  • Female
  • Humans
  • Neoplasm Recurrence, Local / drug therapy*
  • Testosterone / analogs & derivatives*
  • Testosterone / therapeutic use
  • Uterine Cervical Neoplasms / drug therapy*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Testosterone
  • boldenone undecylenate